130 related articles for article (PubMed ID: 25695330)
41. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
42. Expression of the IAPs in multidrug resistant tumor cells.
Notarbartolo M; Cervello M; Poma P; Dusonchet L; Meli M; D'Alessandro N
Oncol Rep; 2004 Jan; 11(1):133-6. PubMed ID: 14654915
[TBL] [Abstract][Full Text] [Related]
43. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
44. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression.
Kweon SH; Song JH; Kim TS
Biochem Biophys Res Commun; 2010 Apr; 395(1):104-10. PubMed ID: 20350534
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine.
Visser N; Lourens HJ; Huls G; Bremer E; Wiersma VR
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652766
[TBL] [Abstract][Full Text] [Related]
47. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.
Rothenburger T; Thomas D; Schreiber Y; Wratil PR; Pflantz T; Knecht K; Digianantonio K; Temple J; Schneider C; Baldauf HM; McLaughlin KM; Rothweiler F; Bilen B; Farmand S; Bojkova D; Costa R; Ferreirós N; Geisslinger G; Oellerich T; Xiong Y; Keppler OT; Wass MN; Michaelis M; Cinatl J
J Exp Clin Cancer Res; 2021 Oct; 40(1):317. PubMed ID: 34641952
[TBL] [Abstract][Full Text] [Related]
48. Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.
Xu S; Zhang YF; Carew MW; Hao WH; Loo JF; Naranmandura H; Le XC
Arch Toxicol; 2013 Jun; 87(6):1013-23. PubMed ID: 23052202
[TBL] [Abstract][Full Text] [Related]
49. Tingenone and 22-hydroxytingenone target oxidative stress through downregulation of thioredoxin, leading to DNA double-strand break and JNK/p38-mediated apoptosis in acute myeloid leukemia HL-60 cells.
Rodrigues ACBDC; Bomfim LM; Neves SP; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Costa EV; da Silva FMA; Rocha WC; Koolen HHF; Bezerra DP
Biomed Pharmacother; 2021 Oct; 142():112034. PubMed ID: 34411914
[TBL] [Abstract][Full Text] [Related]
50. [Effect of Stromal Cell Co-culture on Drug Resistance of Acute Myeloid Leukemia Cells and its Mechanism].
Yue H; Liu LY; Wang XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):382-386. PubMed ID: 28446279
[TBL] [Abstract][Full Text] [Related]
51. Suppression of p38-stress kinase sensitizes quiescent leukemic cells to anti-mitotic drugs by inducing proliferative responses in them.
Vaidya AA; Sharma MB; Kale VP
Cancer Biol Ther; 2008 Aug; 7(8):1232-40. PubMed ID: 18487954
[TBL] [Abstract][Full Text] [Related]
52. Oxidative phosphorylation inhibition induces anticancerous changes in therapy-resistant-acute myeloid leukemia patient cells.
Vitkevičienė A; Janulis V; Žučenka A; Borutinskaitė V; Kaupinis A; Valius M; Griškevičius L; Navakauskienė R
Mol Carcinog; 2019 Nov; 58(11):2008-2016. PubMed ID: 31385375
[TBL] [Abstract][Full Text] [Related]
53. Preclinical activity of FF-10501-01, a novel inosine-5'-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia.
Yang H; Fang Z; Wei Y; Bohannan ZS; Gañán-Gómez I; Pierola AA; Paradiso LJ; Iwamura H; Garcia-Manero G
Leuk Res; 2017 Aug; 59():85-92. PubMed ID: 28599189
[TBL] [Abstract][Full Text] [Related]
54. Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways.
Teng CJ; Cheng PT; Cheng YC; Tsai JR; Chen MC; Lin H
Toxicol In Vitro; 2024 Apr; 96():105768. PubMed ID: 38135130
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
56. Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
Verschuur AC; van Gennip AH; Leen R; Voûte PA; van Kuilenburg AB
Adv Exp Med Biol; 2000; 486():311-7. PubMed ID: 11783507
[No Abstract] [Full Text] [Related]
57. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
[TBL] [Abstract][Full Text] [Related]
58. [Influence of PP2A activator on proliferation of HL-60 cells and analysis of PP2A activity changes in patients with acute myeloid leukemia].
Yang Y; Li XQ; Huang Q; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):594-7. PubMed ID: 21729530
[TBL] [Abstract][Full Text] [Related]
59. [Role of Rheb in Human Acute Myeloid Leukemia].
Wang XM; Xu QZ; Gao YN; Gao J; Li MH; Yang WZ; Wang JX; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):662-6. PubMed ID: 27342487
[TBL] [Abstract][Full Text] [Related]
60. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells.
Leardi A; Caraglia M; Selleri C; Pepe S; Pizzi C; Notaro R; Fabbrocini A; De Lorenzo S; Musicò M; Abbruzzese A; Bianco AR; Tagliaferri P
Br J Haematol; 1998 Aug; 102(3):746-52. PubMed ID: 9722302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
